A Multi-Method Assessment Approach to the Detection of Malingered Pain: Association with the MMPI-2 Restructured Form by Anderson, Jaime L.
Eastern Kentucky University
Encompass
Online Theses and Dissertations Student Scholarship
2011
A Multi-Method Assessment Approach to the
Detection of Malingered Pain: Association with the
MMPI-2 Restructured Form
Jaime L. Anderson
Eastern Kentucky University
Follow this and additional works at: https://encompass.eku.edu/etd
Part of the Clinical Psychology Commons
This Open Access Thesis is brought to you for free and open access by the Student Scholarship at Encompass. It has been accepted for inclusion in
Online Theses and Dissertations by an authorized administrator of Encompass. For more information, please contact Linda.Sizemore@eku.edu.
Recommended Citation
Anderson, Jaime L., "A Multi-Method Assessment Approach to the Detection of Malingered Pain: Association with the MMPI-2
Restructured Form" (2011). Online Theses and Dissertations. 19.
https://encompass.eku.edu/etd/19


 
 
  
 
 
 
 
 
 
 
 
 
A Multi-Method Assessment Approach to the Detection of Malingered Pain: Association 
with the MMPI-2 Restructured Form 
 
 
 
 
 
By 
 
Jaime L. Anderson 
 
 
 
 
 
Thesis Approved: 
 
 
 
 
 
Chair, Advisory Committee 
 
 
 
Member, Advisory Committee 
 
 
 
Member, Advisory Committee 
 
 
 
Dean, Graduate School 
 
 
 
 
  
 
STATEMENT OF PERMISSION TO USE 
 
In presenting this thesis in partial fulfillment of the requirements for a Master of Science 
degree at Eastern Kentucky University, I agree that the Library shall make it available to 
borrowers under rules of the Library. Brief quotations from this thesis are allowable 
without special permission, provided that accurate acknowledgment of the source is 
made. Permission for extensive quotation from or reproduction of this thesis may be 
granted by my major professor, or in his absence, by the Head of Interlibrary Services 
when, in the opinion of either, the proposed use of the material is for scholarly purposes. 
Any copying or use of the material in this thesis for financial gain shall not be allowed 
without my written permission. 
 
 
 
Signature _____________________________________ 
 
 
Date __________________________________________
 
 
A Multi-Method Assessment Approach to the Detection of Malingered Pain: Association 
with the MMPI-2 Restructured Form 
 
 
 
Jaime Anderson 
 
Bachelor of Arts 
University of Dayton 
Dayton, Ohio 
2009 
 
 
 
 
Submitted to the Faculty of the Graduate School of 
Eastern Kentucky University 
in partial fulfillment of the requirements 
for the degree of  
Master of Science 
May, 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
ACKNOWLEDGEMENTS 
 
 I would like to thank my mentor, Dr. Dustin Wygant, for his patience and 
irreplaceable guidance throughout the completion of this project. I would also like to 
thank my other thesis committee members, Dr. Don Beal and Dr. Robert Brubaker, for 
their time and helpful evaluation through this process. Finally, I wish to thank Dr. Robert 
Granacher for the use of this archival data set collected at his private practice.  
 
 
 
iii 
 
Abstract 
 
 The present study investigated the utility of the MMPI-2-Restructured Form 
(MMPI-2-RF) over-reporting scales (F-r, Fp-r, Fs, and FBS-r) and the Response Bias 
Scale (RBS) to detect symptom exaggeration among litigants claiming chronic pain. 
Utilizing the Bianchini et al. (2005) multi-method criteria for Malingered Pain Related 
Disability (MPRD), patients were classified along a continuum ranging from incentive 
only to definite malingering. Malingering classification was found to have a significant 
effect on MMPI-2-RF over-reporting scales, particularly the RBS, Infrequent Symptoms 
Scale (F-r), and Infrequent Somatic Responses scale (Fs), which supports the use of the 
MMPI-2-RF in forensic disability evaluations.  
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Chapter I 
 
 Introduction  
 
Each year, disability fraud costs the United States approximately 6 billion dollars 
(ABC News, May, 2006) and individuals claiming to experience symptoms of chronic 
pain make up a portion of these costs. It is the responsibility of physicians to make 
difficult decisions regarding a claim of disability, and often times, psychologists are 
called upon to provide objective testing in order to evaluate the legitimacy of an 
individual’s claims.  It is important that aids to the reduction of this growing economic 
problem be researched and validated. 
 
Introduction to Response Styles 
 
 Many psychological, somatic, and cognitive dysfunctions are predominately 
experienced internally. Consequently, they can best be measured by self-report methods. 
Indeed, self-report measures are the most widely used and researched personality and 
psychopathology assessment methods (Ben-Porath, 2003). However, while self-report is 
in some cases the sole method to obtain information on the internal experiences of an 
individual; these measures are not without their limitations. When relying on the self-
report of a test-taker, assessing the validity of the results is a necessary component to the 
evaluation. External influences can include the stressful and financial effects of litigation, 
as well as pressure from attorneys, family members, or other individuals of interest 
(Rogers & Bender, 2003). Internal influences on self-report, on the other hand, can 
involve effects of a genuine disorder, a reaction to questioned integrity, the stigmatization 
of mental and physical disorders and disabilities, or the effort of the individual to obtain 
undeserved incentive (Rogers & Bender, 2003).  
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These internal and external influences during test-taking can produce an invalid 
protocol on a self-report measure. Protocol validity is the degree to which an examinee’s 
responses on a psychological test are an accurate representation of his or her 
symptomatology. Ben-Porath (2003) discussed two broad threats to the protocol validity 
of a self-report inventory: non-content and content based invalid responding. Non-content 
based invalid responding is characterized by an individual’s responses being based on 
something other than the accurate reading, processing, and comprehension of the test 
items (e.g. random responding). Content-based invalid responding, on the other hand, is 
characterized by the intentional distortion of test results by the test taker. Individuals 
undergoing psychological assessments, particularly in forensic settings, may intentionally 
distort their psychological characteristics in order to alter assessment results and portray 
themselves in an unrealistic fashion. When an individual undergoing a psychological 
assessment intentionally skews his or her results on the measure, resulting in a misleading 
representation, that individual is said to exhibit content-based invalid responding, or 
response bias.  
 Ben-Porath (2003) also discusses the two types of content-based invalid 
responding: over-reporting and underreporting. The over-reporting of symptoms occurs 
when an individual reports exaggerated symptoms or symptoms that do not exist. 
Underreporting is the opposite; it occurs when an individual lessens his or her symptoms 
or denies that symptoms exist completely. An individual may distort his or her symptoms 
for many different reasons. On one hand, he or she may portray his or her level of 
adjustment in a very positive light in order to appear more appealing to a future employer 
or in order to appear better fit to obtain custody of children in a parental fitness 
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evaluation. On the other hand, an individual may distort him or herself in order to appear 
more impaired, whether it is for attention-based purposes or for a more tangible 
incentive, such as monetary compensation in a civil suit or a lesser criminal sentence in 
light of a diagnosis of a mental illness (e.g., an insanity defense).  
Going beyond the dichotomous classifications of over-reporting or underreporting 
presented by Ben-Porath (2003), Rogers (2008) identified four separate types of response 
bias: nonspecific terms, overstated pathology, simulated adjustment, and other response 
styles, the first three of which will be discussed here. The first of these types, nonspecific 
terms, is a general response style that entails the degree to which an individual’s response 
pattern contains unreliability, nondisclosure, self-disclosure, deception, or dissimulation. 
This response style is a much more general assumption about a pattern of responses than 
a style such as malingering or factitious presentations, both of which involve the 
intentional production of symptoms or symptom exaggeration (APA, 2000). This type 
simply asserts that the information is invalid, and does not also assume the intention of 
the individual behind the invalidation. Unreliability refers to the accuracy of the 
information presented by the individual, nondisclosure is the amount of information the 
individual has withheld, self-disclosure is the amount of information presented by the 
individual about him or herself, deception is the individual’s attempt to distort his or her 
self-representation, and dissimulation is the purposeful distortion by the individual of his 
or her psychological symptoms.  
 Overstated pathology, the second of the over-reporting styles presented by Rogers 
(2008) includes three subtypes. Beginning with the most general of these subtypes, 
feigning is the exaggeration or fabrication of psychological and/or physical symptoms, 
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without any assertion as to the motive behind this exaggerated or fabricated response 
pattern. Factitious presentation, the second subtype, is identified by an individual’s 
intentional invention of physical or psychological symptoms in order to assume a sick 
role (APA, 2000). Finally, malingering, which will be more thoroughly addressed later is 
the intentional exaggeration or production of physical or psychological symptoms, 
motivated by an external incentive (APA, 2000).  
 Defensiveness, social desirability, and impression management are the three 
subtypes of the simulated adjustment response style, the third of the response styles 
presented by Rogers (2008). Again beginning with the most general of these styles, 
impression management is defined as an individual’s intentional attempt to affect the 
opinions others have of him or her, without assumption of the individual’s motive for this 
desired perception. Defensiveness is the deliberate attempt to minimize or deny 
psychological and/or physical symptoms. The third impression management style, social 
desirability, is characterized by the individual attempting to present him or herself in the 
most positive light, which can involve the denial of any presumed negative qualities and 
the attribution of perceived positive or socially desirable qualities.  
 
Malingering 
 
The DSM-IV-TR defines malingering as “the intentional production of false or 
grossly exaggerated physical or psychological symptoms, motivated by external 
incentives such as avoiding military duty, avoiding work, obtaining financial 
compensation, evading criminal prosecution, or obtaining drugs” (APA, 2000, p. 739). 
As suggested in the DSM-IV-TR definition, malingering can become a substantial 
concern in many circumstances, including obtaining medication, work  or military 
 
5 
 
avoidance, and when a case concerns the potential for evading criminal prosecution, or 
financial incentive, as in disability cases.   
Bender (2008) states that malingering falls into four subtypes, ranging from 
transference to the more extreme type, invention. Transference is a type in which an 
individual has problematic symptoms, yet they are not related to or affected by the 
symptoms currently being claimed by that individual. Secondly, there is exaggeration, in 
which, as the name suggests, the individual does in fact have the symptoms presented, 
but the individual has amplified their severity. Preservation is the third type, wherein an 
individual once had the actual symptoms he or she is claiming, however the symptoms 
have since dissipated and the individual is feigning their continuance. The fourth and 
final type of malingering is invention, a type in which the individual does not have and 
has never had the symptoms which he or she is claiming; the symptoms are completely 
fabricated. 
 Malingering, regardless of its type, has been found to have high rates within 
assessment, particularly forensic assessment. A base rate is the number which represents 
the projected prevalence for a condition within a given population. The prevalence, or the 
base rate, of malingering varies from study to study and within different referral 
circumstances (medical, criminal, civil, disability, etc.). Mittenberg, Patton, Canyock, and 
Condit (2002) collected surveys from 131 members of the American Board of Clinical 
Neuropsychology (ABCN), which estimated the percentage of probable malingering 
cases within their practices to range from 8% to 31% across various types of clinical 
settings. Much of this wide range is due to the range of referral circumstances for which 
malingering would be assessed. The base rate of malingering in, for example, a chronic 
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pain setting is different than the base rate of malingering in head injury claims. For 
instance, it has been estimated that probable malingering has base rates of 39% in mild 
head injury claims, 35% with fibromyalgia/chronic fatigue, 31% of chronic pain, 27% of 
neurotoxic, and 22% of electrical injury claims (Mittenberg, Patton, Canyock, & Condit, 
2002). While varying studies report slight variations of these estimates due to differing 
domains and referral questions, each study presents an estimated base rate that suggests 
the importance of the accurate detection of malingering, regardless of the referral 
circumstances. Overall, if malingering measures were to be administered in all referrals, 
it is estimated that the base rate would fall between 10-30% (Rogers, 2008). 
 
Relevance to Forensic Psychology 
 
 Malingering is an issue of particular importance in a forensic setting. 
Psychologists are often called upon to provide psychological assessments in civil and 
criminal cases. In a civil case, financial stakes can be extremely high, giving any 
involved individual incentive to feign or exaggerate symptoms (Wygant, Ben-Porath, 
Arbisi, Berry, Freeman, & Heilbronner, 2009). A psychologist utilizing assessment 
measures is able to provide the legal system with an objective measure of an individual’s 
probability of malingering. Given that forensic psychology is a context in which much is 
typically at stake for an individual undergoing a psychological assessment, the 
assessment measures for malingering becomes an integral clinical consideration for any 
forensic assessment battery. Though base rates of malingering in forensic settings vary, 
each estimate identifies a significant minority of individuals who fall into a probable or 
definite malingering category (Mittenberg, Patton, Canyock, & Condit, 2002), which can 
have a significant effect on the judicial system.  
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 In regards to disability claims, financial incentive produces a major influence on 
the rates of malingering. According to the National Insurance Crime Bureau, in the first 
quarter of 2009, worker’s compensation fraud increased 71% from the previous year 
(Florida Department of Financial Services, 2009). An accurate and efficient method of 
malingering detection in these situations is important so as to prevent individuals 
malingering their symptoms from obtaining health care resources that would be more 
deserved by individuals who have genuine substantial disabilities (Bianchini, Greve, & 
Glynn, 2005).  
 
DSM Diagnosis 
 
 It has long been recognized that the Diagnostic and Statistical Manual from the 
American Psychiatric Association (DSM; APA, 2000) provides little guidance in 
assessing malingering (see Rogers, 2008 for extensive discussion of this topic). While the 
DSM provides an accurate definition of what malingering entails, it does not provide 
clinicians and researchers with an objective and measureable method to systematically 
diagnose when it occurs. Currently classified as a V-code under Additional Conditions 
That May Be a Focus of Clinical Attention, malingering, as defined in the DSM-IV-TR, 
lacks criteria to diagnose this problematic clinical behavior. While the DSM-IV-TR does 
list conditions under which malingering should be suspected and thus assessed (APA, 
2000), these conditions do not assist a clinician on how to assess for malingering when 
the mentioned conditions have been met. Even the use of the DSM-IV-TR in screening 
individuals for possible malingering has failed entirely. In fact, in a criminal forensic 
screening, use of the DSM-IV-TR malingering criteria alone has rendered a false-positive 
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rate of around 80% (Rogers, 1990), suggesting this lack of DSM-IV-TR criteria is a 
significant problem. 
 
Alternative Diagnostic Criteria  
  
 It is due to this lack of criteria that separate and more specific diagnostic criteria 
outside of the DSM-IV-TR system have been established, most notably the diagnostic 
criteria of Slick et al. (1999) and Bianchini et al. (2005) (utilized later in this study). Slick 
and colleagues (1999) responded to this growing problem of a lack of measureable and 
systematic criteria by establishing their own diagnostic criteria to detect malingered 
neurocognitive dysfunction (MND). Following the lead of these researchers, Bianchini 
and colleagues (2005) later established related criteria to detect malingered pain related 
disability (MPRD). Each list of proposed criteria is used to assess the degree of symptom 
feigning, ranging from possible malingering, to probable malingering, to definite 
malingering. 
 Prior to the publication of the Bianchini et al. criteria, malingered pain was 
assessed using the Slick et al. MND criteria. For instance, Etherton and colleagues (2005) 
used the Slick et al. criteria in a study determining the sensitivity and specificity of the 
Reliable Digit Span measure in assessing malingered pain. 
 Although the Slick et al. criteria have been applied in malingered pain studies, the 
symptoms evaluated in these studies are limited to cognitive impairment complaints. The 
later established Bianchini et al. criteria addressed this problem with the development of 
specific criteria for identifying MPRD. These criteria are a potential asset in a medico-
legal context, as MPRD has been found to be a prevalent issue. In fact, among pain 
patients, the most reliable estimates of malingered disabilities are between 20%-40% 
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(Greve, Ord, Bianchini, & Curtis, 2009).  The growing trends of disability related to 
chronic pain are reflective of an epidemic (Melhorn, Lazarovic, & Roehl, 2009), making 
the accurate detection of MPRD an important clinical and social issue. The development 
of the Bianchini et al. criteria enables clinicians to make determinations regarding the 
possibility to malingering specifically in the domain of these physical symptom 
complaints.  
 The MPRD have already been examined with the Minnesota Multiphasic 
Personality Inventory-2 (MMPI-2). Bianchini and colleagues (2008) utilized the MPRD 
criteria in order to determine the accuracy of the validity scales included on the MMPI-2 
in detecting malingered pain-related disability. Individuals classified as definite MPRD 
were found to have higher scores on the MMPI-2 over-reporting validity scales in 
general. Specifically, FBS and Fb were found to have the largest effect sizes in 
distinguishing individuals who were malingering from those determined to respond 
honestly.   
 As previous research has shown, the Slick et al. (1999) and the Bianchini et al. 
(2005) criteria may be considered a suitable addition to the use of the definition of 
malingering presented in the DSM-IV-TR (APA, 2000) in the diagnosis of malingered 
pain related disability and malingered neurocognitive dysfunction. Each of these sets of 
criteria provides an assessor with the tools to objectively measure the possibility of 
malingering. With criteria regarding performance on neuropsychological measures 
(particularly symptom validity tests) and evidence obtained from self-report measures, a 
clinician is able to form a more distinct picture of that individual’s probability of 
malingered pain related disability or neurocognitive dysfunction. The two sets of criteria 
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even allow the assessor to determine different levels of malingering, indicating the 
likelihood of malingered symptomatology. While the DSM-IV-TR presents criteria that 
are very broad, subjective, and open to the clinician’s interpretation, the Bianchini et al 
and the Slick et al criteria enable the clinician to place an individual in one of three 
categories of malingering by use of performance on valid and reliable assessment 
measures.  
 
Domains of Malingering 
 
 Feigning, and in particular, malingering can be broken down into three domains. 
These domains are psychopathology, neurocognitive dysfunction, and physical/somatic 
dysfunction.  Any particular individual’s response bias may not be limited to one domain 
within malingering. An examinee attempting to misrepresent him or herself may attempt 
to feign symptoms which fall within any combination of the three domains. For example, 
an individual reporting chronic pain may also present with decreased performance on 
measures used to detect cognitive dysfunction. Research by Burchett and Ben-Porath 
(2010) has shown this through the use of the self-report personality inventory, the 
Minnesota Multiphasic Personality Inventory-2- Restructured Form (MMPI-2-RF; 
Tellegen & Ben-Porath, 2008). Their research demonstrated that individuals instructed to 
feign symptoms of psychopathology not only obtained the highest scores on scales 
measuring psychological dysfunction, but also scored highest (in some cases significantly 
higher than the somatic feigning simulation group) on scales designed to measure somatic 
symptoms.    
 Reported base rates for malingering differ across these three different domains. 
Within the psychological dysfunction domain, researchers have estimated that up to 20% 
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of criminal forensic cases and 30% of civil forensic cases involve over-reporting of 
psychological symptoms (Mittenberg, Patton, Canyock, & Condit, 2002; Rogers, Salekin, 
Sewell, Goldstein, & Leonard, 1998; Rogers, Sewell, & Goldstein, 1994). Within the 
physical/somatic domain, the base rates for malingering among chronic pain patients 
ranges from 20-50% (Greve et al., 2009). In addition, Greve and colleagues (2009) found 
that, though the majority of pain patients in their sample did not meet the full criteria for 
malingering, nearly half of the sample exhibited some evidence of symptom exaggeration 
on symptom validity measures. Finally, within the domain of cognitive dysfunction, 
malingering base rates in mild head injuries cases have been found to fall between 38-
41% (Mittenberg, Patton, Canyock, & Condit, 2002).   
 
Detecting Response Bias and Malingering 
 
 Each domain of malingering will have a different clinical presentation, and so, 
each domain in turn has varying detection strategies (Rogers & Bender, 2003). As would 
be expected, there are different validity measures designed to detect the malingering of 
psychological symptoms than those designed to detect the malingering of somatic 
symptoms. However, as previously stated, malingering individuals may present 
symptoms falling in multiple domains, so examinees should be administered detection 
measures representative of each domain in which the individual is suspected to be 
malingering.  
 
Detection of Feigned Psychological Symptoms 
 
 The detection of feigned psychological symptoms typically involves the use of 
self-report measures and structured interviews. Given that psychological and psychiatric 
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symptoms represent internal experiences that need to be expressed through self-report, 
the premise of most methods for detecting malingering in this domain is that the 
individual will report experiences that are inconsistent with a genuine or common 
representations of mental illness (Wygant, 2007). Rogers (2008) identified several 
methods utilized in the detection of feigning. These methods employ the use of 
indentifying rare symptoms, quasi-rare symptoms, improbable symptoms, symptom 
combinations, spurious patterns of psychopathology, indiscriminant symptom 
endorsement, symptom severity, obvious symptoms, reported versus observed symptoms, 
and erroneous stereotypes. In identifying those preceding aspects of an individual’s 
responses, assessors can see the endorsement of symptoms that are rarely and not likely 
to be claimed by genuinely mentally ill individuals, unlikely symptom combinations, 
symptoms which are not supported by the observed behavior of the individual, or 
symptoms that are endorsed due to a false stereotype about symptoms of the mental 
illness an individual is attempting to feign.  
 Several personality inventories have built-in validity scales in order to detect 
response bias. There are in fact two widely used inventories that have been shown to 
accurately detect response bias and, in particular, over-reporting. The Minnesota 
Multiphasic Personality Inventory-2 (MMPI-2; Butcher, Graham, Ben-Porath, Tellegen, 
Dahlstrom, & Kaemmer, 2001), which will later be addressed in detail, and the 
Personality Assessment Inventory (PAI; Morey, 1991, 2007), both of which have built-in 
validity scales which can be used to detect feigning (Rogers & Bender, 2003). Most of 
the built-in validity scales in these personality measures use the rare or unlikely symptom 
approach to determine if an individual’s personality profile is exaggerated. 
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 In addition to personality inventories with built-in validity scales, there have also 
been separate validity measures, in the form of structured interviews, specifically aimed 
to detect malingering, two of which are aimed toward detecting feigned psychological 
dysfunction. The Structured Interview of Reported Symptoms (SIRS; Rogers, Bagby, & 
Dickens, 1992) uses each of the detection methods discussed by Rogers (2008), with the 
exception of erroneous stereotypes (Rogers & Bender, 2003). Used for the systematic 
assessment of malingered mental disorders, the SIRS classifies interviewees into three 
categories: feigning, indeterminate, and non-feigning (Rogers, Bagby, & Dickens, 1992). 
Its most recent version, the Structured Interview of Reported Symptoms-Second Edition 
(SIRS-2; Rogers, Sewell, & Gillard, 2010) breaks the continuum down even further by 
classifying individuals into four categories: genuine responding, indeterminate-general, 
indeterminate-evaluate, and feigning. The Miller Forensic Assessment of Symptoms Test 
(M-FAST; Miller, 2001) is a structured 25-item screening measure validated to assess for 
malingered psychopathology. Through the use of seven different scales it utilizes several 
of the methods identified by Rogers (2008), including reported versus observed 
symptoms, symptom severity, and rare combinations. In addition, however, this measure 
also includes a suggestibility item, which in known groups of individuals with genuine 
psychopathology was never endorsed (Miller, 2001).  
Finally, there is also a self-administered multi-axial inventory, the Structured 
Inventory of Malingered Symptomatology (SIMS; Widows & Smith, 2005), that is used 
to detect not only symptom feigning in the psychological domain, but also in the 
neurocognitive domain. This 75-item screening measure utilizes five different scales 
measuring feigned psychosis, neurological impairment, amnestic disorders, low 
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intelligence, and affective disorders (Widows & Smith, 2005). When using a sample of 
college simulators, Widows and Smith (2005) found that the SIMS exhibited high 
sensitivity and specificity with its cut off score of ≥14. 
 
Detection of Feigned Neurocognitive Symptoms 
 
 In addition to the SIMS, several other unique detection strategies have been used 
in the identification of MND. These measures differ from the typical measures used to 
detect malingered psychopathology because they must focus specifically on cognitive 
symptoms (Rogers & Bender, 2003).  
  Reliable Digit Span (RDS; Greiffenstein, Baker, & Gola, 1994) is an internal 
validity measure developed from digit span tests found on several common clinical 
neurological tests, such as the Wechsler Adult Intelligence Scale-IV (WAIS-IV; 
Wechsler, 2008), the Wechsler Memory Scale-IV (WMS-IV; Wechsler, 2009), the 
Stanford-Binet-V (SB-V; Roid, 2003), and the Neuropsychological Assessment Battery 
(Stern & White, 2003). Individuals may attempt to exaggerate or fabricate their 
impairment on digit span tests based on their assumption that the test seems to be one on 
which individuals with brain injuries will perform poorly (Meyers & Volbrecht, 1998). 
However, individuals with genuine brain dysfunction, even amnesia, tend to have fairly 
well preserved the skills needed to complete digit span tasks (Greiffenstein, Baker, & 
Gola, 1994). Generally, RDS scores of 7 or lower have been associated with a specificity 
of more than 90% in both brain-injured and healthy individuals (Larrabee, 2003; Meyers 
& Volbrecht, 1998). Therefore, an RDS score 7 or lower is rarely or never seen in 
individuals with genuine brain dysfunction, and scores in this range imply poor effort 
and/or response bias (Etherton, Bianchini, Greve, & Heinly, 2005).  
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 The Post-Concussive Symptom Questionnaire (PCSQ) is a brief self-report 
measure used to evaluate symptom validity among individuals presenting with 
neurocognitive complaints. Tsanadis and colleagues (2008) found that the PCSQ was 
able to discriminate between individuals with genuine traumatic brain injury and 
individuals meeting the criteria for at least probable malingering. Van Dyke and 
colleagues (2010) found similar results, showing that the PCSQ measures significant 
variance distinct from cognitive performance.  
 Symptom validity tests (SVT) and their abilities to accurately detect malingering 
have been a major focus point within neuropsychology (Bianchini, Mathias, & Greve, 
2001). First used to detect exaggerated memory complaints by Pankratz in 1983 
(Bianchini, Mathias & Greve, 2001), the use of SVT’s has grown and several different 
symptom validity measures have been established. Of those currently used, the first was 
the Digit Memory Test (DMT), where an individual is given a string of numbers and later 
asked to recognize which string was seen on a forced choice recognition test (Hiscock & 
Hiscock, 1989). This format is typical of SVTs; most measures involve forced-choice 
recognition tasks over a series of trials (Bickart, Meyer, & Connell, 1991). Very similar 
in format to the DMT is the most widely used SVT, the Portland Digit Recognition Test, 
which requires the test taker to be able to recognize 72 five-digit strings of numbers 
(Binder, 1993). In contrast to the DMT, however, this test has a perceived increase in 
difficulty, as it utilizes differing lengths of distracter techniques between trials (Binder, 
1993). Again, stemming from the DMT is the Victoria Symptom Validity Test (VSVT), 
which is a shortened computerized version of the original Digit Memory Test (Slick, 
Hopp, & Strauss, 1995). Finally, differing from the aforementioned SVTs in that it 
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involves a picture recognition task, is the Test of Memory Malingering (TOMM; 
Tombaugh, 1996). The TOMM has been validated by having high correct response rates 
with genuinely neurologically impaired individuals (Tombaugh, 1997), and it is one of 
the most comprehensively studied symptom validity tests (Bianchini, Mathias, & Greve, 
2001).  
Due to the nature of these detection strategies, there are several reasons beyond 
malingering that a person could perform below his or her ability level. These reasons can 
include genuine cognitive impairment, a comorbid condition such as depression, 
expectations of failure, stress, or reactions to inferences from the assessor that his or her 
impairment is trivial (Rogers & Bender, 2003). However, the multi-method assessment 
approach proposed by Bianchini et al. (2005) assumes individuals indentified as probably 
or definite malingering will not be identified as such due to genuine dysfunction or sole 
lack of effort. This further necessitates the use of multiple detection measures (self-
report, SVT’s, interviews, etc.)   
 
Detection of Feigned Physical/Somatic Symptoms 
 
 Granacher and Berry (2008) suggest that the domain of physical/somatic 
malingering has proven to be the most difficult form of malingering to detect. This is 
largely due to effects of genuine physical disorders or from the difficulty for clinicians to 
differentiate between malingering and a psychological disorder such as conversion or 
factitious disorders. Physical/somatic malingering is often presented by an individual as 
neurological impairment, however, any physical condition can be malingered (Granacher 
& Berry, 2008). When neurological symptoms are reported, typical detection strategies 
for neurological malingering can be utilized. For instance, RDS has been found to be 
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effective in detecting malingering amongst individuals reporting pain-related disability 
(Etherton, Bianchini, Greve, & Heinly, 2005). Since symptoms presented are not always 
neurological, more physical and somatically based measures must be utilized to detect 
malingering in this form. In either case, assessors must use detection methods that are 
based on non-anatomical or non-physiological presentations of physical disorders 
(Granacher & Berry, 2008).  
 Beyond the use of measures such as SVT’s and various neurological tests in 
detecting MPRD, other measures have been found to be effective. One such measure is 
the PAI (Morey, 1991).  The PAI includes indicators related to somatic symptoms, such 
as the Somatic Complaints Scale (SOM), which differentiated pain patients from healthy 
respondents (Karlin, Creech, Grimes, Clark, Meagher, & Morey, 2005), along with 
several other scales including those which assess depression, anxiety, and treatment 
motivation, which have been found to be important in assessing the impact of pain (Turk 
& Okifuji, 2002). Hopwood and colleagues (in press) have found that the PAI’s validity 
scales have significant effect sizes in differentiating between genuine pain patients and 
individuals attempting to feign pain-related symptoms. The researchers also found that 
even when simulators were coached on the existence of the validity indicators within the 
test, there was a minimal effect on improved ability to feign. Finally, the researchers 
found that SOM scale scores were higher for the individuals attempting to feign somatic 
symptoms than for individuals with genuine somatic complaints, thus demonstrating the 
effectiveness of the PAI in the detection of malingered pain related disability.  
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Malingering and the MMPI-2 
 
 The MMPI-2 and MMPI-2-RF are two other personality inventories used to detect 
malingering across all domains. The MMPI-2 is a 567 true or false self-report 
questionnaire that is the most widely used psychological test in the United States 
(Graham, 2006). In addition, this measure stands as the most extensively researched 
psychological measure of feigned mental disorders (Rogers, Sewell, Martin, & Vitacco, 
2003). This measure includes built-in protocol validity scales used to detect inconsistent 
responding, random responding, defensiveness, and the over-reporting of symptoms.  
 The MMPI-2 validity scales used to detect feigning include the F (Infrequency) 
scale, Fp (F-Psychiatric) scale, Fb (Back Infrequence) scale, and FBS (Symptom 
Validity) scale, along with the more recent addition of the experimental RBS (Response 
Bias Scale; Gervais, Ben-Porath, Wygant, & Green, 2007) scale.  Extensive research has 
been conducted in order to show the validity of these scales in detecting the exaggeration 
or fabrication of symptoms. According to Rogers and colleagues (2003), the MMPI-2 
employs the rare symptoms, symptom severity, obvious versus subtle symptoms, 
symptom selectivity, and erroneous stereotypes strategies within the validity scales aimed 
toward the detection of feigning. Most notable of these strategies are the rare symptoms 
and erroneous stereotypes approaches.  
 The rare symptoms approach is a strategy used in the F, Fb, and Fp scales based 
on features that are very infrequently reported by genuine clinical populations (Rogers, 
2008). This strategy is based upon the assumption that individuals attempting to feign 
symptoms will be unable to differentiate between genuine features and these seemingly 
appropriate symptoms found within these validity scales. The F and Fb scales were 
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created based on the items endorsed by individuals from the normative sample. However, 
from a rare symptoms approach, these two scales are limited in that at least fifteen items 
on the F scale are endorsed by 25% of individuals from a clinical sample (Greene, 1997). 
Therefore, when the F or Fb scale is elevated, it could be due to the feigning of symptoms 
however, it could also be a matter of the individual having a genuine psychological 
disorder which would cause this scale elevation.  It was through the development of the 
Fp scale (Arbisi & Ben-Porath, 1995) that this rare symptoms limitation was addressed; 
this scale is used to identify rarely endorsed symptoms from a genuine clinical 
population.  Indeed, it has been found that the F and Fp scales have the largest average 
effect sizes in the detection of feigning (Rogers, Sewell, Martin, & Vitacco, 2003; Arbisi 
& Ben-Porath, 1995).  
 Erroneous stereotypes is an approach toward detecting feigning that utilizes items 
on the MMPI-2 that individuals attempting to exaggerate or fabricate symptoms would 
falsely associate with a certain condition. The development of the FBS scale (Lees-Haley, 
English & Glenn, 1991) utilized this erroneous stereotypes strategy in order to provide a 
validity measure specific to individuals attempting to feign symptoms within a personal 
injury case. Research has later shown that the scale is also effective in the detection of 
exaggerated somatic symptoms (Larrabee, 1998, 2003). Although the FBS scale has been 
faced with criticism for its narrow focus and possible high false positive rate (e.g. Rogers, 
Sewell, Martin, & Vitacco, 2003; Butcher, Arbisi, Atlas & McNulty, 2003), a meta-
analysis by Nelson and colleagues (2010) found that the FBS performed as well, if not 
better, than other scales used in the detecting the over-reporting of psychological 
symptoms. The researchers found that, in particular, the FBS is useful is determining 
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effort status and TBI, even finding that the FBS has larger effect sizes in comparison to 
other validity scales (F, Fb, and Fp) in these areas. This was shown by Ross and 
colleagues (2004) who found that the FBS scale is capable of discriminating between 
non-litigating individuals with confirmed traumatic brain injury and litigating individuals 
who showed poor effort. Consequently, the Symptom Validity Scale was added to the 
official list of scored validity scales on the MMPI-2. 
 The RBS was designed for the MMPI-2 as a measure specifically developed to 
sensitively detect cognitive response bias and predict an individual’s failure on SVT’s 
(Gervais, Ben-Porath, Wygant, & Green, 2007). Although FBS scores have been found to 
be more elevated by individuals who fail SVT’s than individuals who do not in both 
criminal and civil forensic settings (Wygant, Sellbom, Ben-Porath, Stafford, Freeman, & 
Heilbronner, 2007), the RBS has been found to be an effective addition to the standard 
MMPI-2 validity scales (Gervais, Ben-Porath, Wygant & Green, 2007). RBS scores have 
been found to be unlikely to elevate due to genuine memory deficits and its utility 
(Gervais, Ben-Porath, Wygant & Green, 2007). Furthermore, the RBS has been found to 
be useful in identifying individuals with poor performance on SVT’s as well as 
identifying individuals with secondary gain among both criminal and civil forensic 
groups (Nelson, Sweet, & Heilbronner, 2007; Wygant, Ben-Porath, Gervais, Sellbom, 
Stafford, & Freeman, et al. 2010).   
 
Malingering and the MMPI-2-RF 
 
The MMPI-2-RF is a revised form of the MMPI-2 consisting of 338 true or false 
items (Ben-Porath & Tellegen, 2008). Much like its previous version, this measure 
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includes built-in protocol validity scales used to detect inconsistent responding, random 
responding, defensiveness, and the over-reporting of symptoms. 
The MMPI-2-RF uses four over-reporting validity scales, including the F-r 
(Infrequent Responses) scale, the Fp-r (Infrequent Psychopathology Responses) scale, the 
Fs (Infrequent Somatic Responses) scale, and the FBS-r (Symptom Validity) scale. In 
addition, RBS, originally developed for the MMPI-2, can be scored on the MMPI-2-RF 
in its entirety. Gervais, Ben-Porath, Wygant, & Green (2007) developed RBS as a scale 
indicative of poor performance on cognitive SVT’s and research has been promising 
regarding its effectiveness  in doing so in both disability (Gervais, Ben-Porath, Wygant, 
& Green, 2007; Gervais, Ben-Porath, Wygant, & Green, 2008) and criminal forensic 
settings (Wygant, Sellbom, Gervais, Ben-Porath, Stafford, Freeman, & Heilbronner, 
2010). Furthermore, RBS was found to outperform the original MMPI-2 validity scales in 
predicting poor performance on the TOMM (Whitney, Davis, Shepard, & Herman, 2008). 
The Infrequent Somatic Responses (Fs; Wygant, Ben-Porath, & Arbisi, 2004) scale, 
designed specifically for the MMPI-2-RF, was developed to measure over-reported 
somatic complaints using the traditional infrequency approach. Research by Wygant 
(2007) showed that the scale is significantly elevated among samples of individuals who 
failed SVT’s and individuals who were instructed to feign somatic symptoms. In 
addition, the scale was found to add incrementally to the original MMPI-2 validity scales 
in detecting response bias.  
Wygant, Gervais, and Ben-Porath (2010) have utilized the MMPI-2-RF in the 
study of neurocognitive malingering and the Slick et al. (1999) criteria for detecting 
malingered neurocognitive dysfunction. These authors found that over-reporting validity 
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scales were significantly elevated for patients classified in the probable or definite 
malingering group in comparison to patients classified as non-malingering. RBS and F-r 
were found to have the largest effect sizes in detecting malingering in the neurocognitive 
domain. This suggests that the MMPI-2-RF is congruent with the Slick et al. (1999) 
criteria in detecting MND. In a similar study, Gervais and colleagues (2010) found that 
the overreporting scales and RBS were significantly elevated in a sample of patients with 
low performance on measures designed to detect feigned memory complaints. 
Furthermore, Youngjohn and colleagues (2011) found that FBS-r accounted for a 
significant amount of variance in the detection of individuals who had failed formal effort 
tests. These studies, again, confirm the effective utility of the MMPI-2-RF in the 
detection of neurocognitive malingering.     
The MMPI-2-RF has also been utilized in the detection of over-reported 
psychopathology. Sellbom and Bagby (2010) found that the MMPI-2-RF validity scales 
(F-r, Fp-r, Fs, and FBS-r) were effective in discriminating between individuals instructed 
to feign psychopathology and a known-group of severely mentally-ill psychiatric hospital 
patients. In fact, even when simulators were coached on the validity scales on the MMPI-
2-RF, over-reporting scale scores with the exception of those from FBS-r remained 
significantly higher than the scores obtained by the sample of known psychiatric patients.  
Specific to the realm of forensic psychology, the MMPI-2-RF has been researched 
in regards to the detection of malingering within both criminal and civil forensic settings. 
Sellbom and colleagues (2010) found, using a criterion-groups design, that the MMPI-2-
RF over-reporting validity scales (F-r, Fp-r, Fs, and FBS-r) were effective in detecting 
malingered psychopathology among a sample of criminal defendants, with F-r and Fp-r 
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producing the largest effect sizes. In a study by Wygant and colleagues (2009), consisting 
of a sample of both medical and head injury simulators along with personal injury and 
disability claimants, similar positive results were obtained. F-r, Fp-r, and Fs were 
significantly elevated for exaggerated neurocognitive symptom groups in comparison to 
controls and all over-reporting scales analyzed (F-r, Fp-r, Fs, and FBS-r) were 
significantly elevated in the medical symptom exaggeration group in comparison to 
controls. Results of these studies show positive results in regards to the use of the MMPI-
2-RF in detecting malingering across forensic settings and varying domains of 
malingering.  
 
The Present Study 
 
 The current study investigates the utility of the MMPI-2-RF in the detection of 
somatic/physical malingering. While previous studies have shown encouraging results in 
regards to the MMPI-2-RF effectively discriminating between individuals who are and 
are not malingering, farther research is needed. The present investigation adds to previous 
research for several reasons. The participants were classified using the Bianchini et al. 
criteria designed specifically for the detection of malingered pain. This expands on 
previous research as it eliminates the use of neurocognitive malingering classifications 
being utilized in the classification of somatic malingering. In addition, the use of this set 
of criteria demands that participants be given a large battery of measures in order to 
employ a multi-model strategy of detection. Furthermore, this study uses a known groups 
design consisting of disability claimants reporting chronic pain, which improves upon 
former studies using college student simulators.  
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 The purpose of this investigation was to examine the utility of the MMPI-2-RF in 
detecting malingering among a sample of individuals classified using criteria for the 
detection of malingered pain-related disability. In regards to malingering classification, it 
was first hypothesized that each over-reporting scale would be significantly elevated for 
participants classified as malingering in comparison to participants classified in a non-
malingering group. In particular, it is hypothesized that F-r and RBS will perform the 
best at discriminating between malingering and non-malingering groups, given that 
previous research has demonstrated their utility in civil forensic settings (Gervais et al., 
2010; Wygant et al., 2010). However, given the nature of the referral (pain/physical 
injuries), it is also anticipated that Fs will exhibit utility in making these classifications, 
given that this scales was designed to assess non-credible somatic responding (Tellegen 
& Ben-Porath, 2008; Wygant et al., 2009). It is anticipated that Fp-r, which was 
developed to measure over-reporting of severe psychopathology, will show the least 
utility in classifying litigants in this sample, given the nature of this civil (versus 
criminal) setting and this scale was developed to measure exaggerated severe 
psychopathology.  
 In regards to the symptom presentation of the malingering group, it is 
hypothesized that individuals who are classified as malingering will have significantly 
elevated scores on the Restructured Clinical scales, specifically RC1 (Somatic 
Complaints) and RC2 (Low Positive Emotions), both of which should be conceptually 
related to pain.  
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Chapter II 
Method 
Participants 
 This archival sample comprised 169 individuals evaluated by Dr. Robert 
Granacher at his forensic neuropsychiatric practice in Lexington, KY between 2001 and 
2004 for the purpose of disability determination. Each participant received an evaluation 
based on self-reported symptoms of chronic pain. The sample was predominantly male 
(68%) and Caucasian (94%) with a mean age of 41.1 (SD = 9.4) and mean education of 
11.7 years (SD = 2.3). 
 
Instruments 
 
Self-Report Measures:  
 MMPI-2-Restructured Form (MMPI-2-RF). Participants were administered the 
MMPI-2. However, because this study focuses on the utility of the MMPI-2-RF scales to 
detect malingered pain-related disability, the MMPI-2-RF scales were archivally scored 
from the full MMPI-2 administration. Previous research has established the equivalence 
of scale scores produced with the two versions of the instrument (Tellegen & Ben-Porath, 
2008; Van Der Heijden, Egger, & Derksen, 2010). 
Structured Inventory of Malingered Symptomatology (SIMS; Widows & Smith, 
2005). The SIMS is a self-report measure used to detect malingering consisting of 75 
true/false items. The test includes five subscales, including Psychosis (P), Neurologic 
Impairment (NI), Amnestic Disorders (AM), Low Intelligence (LI), and Affective 
Disorder (AF), each of which assesses a separate domain of symptom exaggeration. 
When using a sample of college simulators, Widows and Smith (2005) found that the 
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SIMS exhibited a sensitivity of 95% and a specificity of 88% with a cut off score of ≥14. 
However, research by Wisdom et al. (2010) in relation to the Slick et al. (1999) criteria 
for malingered neurocognitive dysfunction found that the SIMS cutoff of 14 resulted in a 
36% false positive rate in the classification of malingering. In fact, these authors found 
that a Total Score cutoff of > 23 was necessary for a false positive rate of less than 10% 
and a specificity of .55. 
Interview-based response bias measures: 
Miller Forensic Assessment of Symptoms Test (M-FAST; Miller, 2001). The 
Miller Forensic Assessment of Symptoms Test (M-FAST; Miller, 2001) is a structured 
25-item screening measure validated to assess for malingered psychopathology. The M-
FAST includes seven scales, Reported vs. Observed (RO), Extreme Symptomatology 
(ES), Rare Combinations (RC), Unusual Hallucinations (UH), Unusual Symptom Course 
(USC), Negative Image (NI), and Suggestibility (S). Research by Miller (2001) showed 
that in a clinical sample the recommended a cutoff score of 6 for the Total Score 
produced a negative predictive power (NPP) of .97, positive predictive power (PPP) of 
.68, specificity of .83, and sensitivity of .93. This cutoff score has had similar support in 
farther research (Miller, 2004; Guy & Miller, 2004).  
 Structured Inventory of Reported Symptoms (SIRS; Rogers, Bagby, & Dickens, 
1992). The SIRS is a 172-item structured interview designed to capture various over-
reported response styles.  It includes eight primary scale, including Rare Symptoms, 
Improbable and Absurd Symptoms, Symptom Combinations, Blatant Symptoms, Subtle 
Symptoms, Symptom Severity, Symptom Selectivity, and Reported vs. Observed 
Symptoms. Scores are classified into three categories: feigning, indeterminate, and non-
 
27 
 
feigning. Previous studies have illustrated internal consistencies ranging from .77 - .96 
for the various scales in addition to having inter-rater reliability ranging from .97 - 1.00 
(Rogers, Bagby & Dickens, 1992; Ustad, 1998; Vitacco, Rogers, Gabel, and Munizza, 
2007).  
Cognitive symptom validity measures: 
 Test of Memory Malingering (TOMM; Tombaugh, 1996) is a widely used visual 
recognition test. The TOMM is one of the most comprehensively studied symptom 
validity tests (Bianchini, Mathias, & Greve, 2001) and previous work (Rees, Tombaugh, 
Gansler, and Moczynski, 1998) has found the TOMM to produce high sensitivity and 
specificity rates in distinguishing between individuals with genuine impairment and 
feigning simulators.  
 Victoria Symptom Validity Test (VSVT; Slick, Hopp, Strauss, & Thompson, 
1997). The VSVT is a computerized forced-choice digit recognition test. Performance 
falls into three categories: Valid, Questionable, or Invalid. Research by Slick, Hopp, 
Strauss, Hunter, and Pinch (1994) using control groups consisting of non-compensation-
seeking post-concussion patients, and unimpaired participants feigning post-concussion 
syndrome found that all control participants performed above cutoffs for malingering 
(i.e., 100% specificity). In addition, 83% of the simulators feigning dysfunction scored in 
the questionable or invalid range (i.e., 83% sensitivity).  
 Letter Memory Test (LMT; Inman, Vickery, Berry, Lamb, Edwards, & Smith, 
1998). The LMT is a computer administered forced-choice letter recognition test. Inman 
and colleagues (1998) found that a performance cut-off of 93% exhibited a sensitivity of 
.84 among analogue malingerers, .95 among traumatic brain injury patients with poor 
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effort scores on the Digit Memory Test, while exhibiting a specificity of 1.00 for non-
compensation seeking neurological patients.  
 
Procedure 
 
Upon completion of the assessment battery, the individual tests were scored 
according to their respective manuals and research criteria, which are presented in Table 
1
1
. We then grouped participants into one of four classifications based on the Bianchini et 
al. (2005) criteria for Malingered Pain Related Disability (MPRD). These criteria 
included the presence of external incentive (Criterion A), performance on cognitive 
symptom validity tests (Criterion C1-C2), discrepancies between reported and observed 
behavior (Criterion D4) and scores on the SIRS, M-FAST, and SIMS for Criterion D5. In 
no case could a psychiatric, developmental, or neurological disorder fully account for 
classifications of malingering. Therefore, no participants were excluded for Criterion E. 
Participants were classified as either Incentive Only (n = 68), Possible Malingering (n = 
35), Probable Malingering (n = 55), or Definite Malingering (n = 15).  
 
Statistical Analyses 
 
It was hypothesized that participants in the probable/definite malingering group 
actually exaggerate their symptom presentation relative to the non-malingering 
participants on the clinically substantive measures of the MMPI-2-RF (Restructured 
Clinical scales).  To examine this, a one-way multivariate analysis of variance 
(MANOVA) was utilized to assess if malingering and non-malingering groups have 
                                                          
1
 All Tables and Figures can be found in the Appendices. 
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significant scale score differences for the Higher Order, Restructured Clinical, and 
Somatic/Cognitive Specific Problems scales on the MMPI-2-RF.  
To examine whether the scales exhibit significant mean differences across the 
various pain malingering classifications, another one-way MANOVA was used.  
Finally, classification analyses were conducted to examine the accuracy of 
various cut scores for the MMPI-2-RF validity scales in determining the classification of 
malingering.  In particular, the accuracy of classification was examined in relation to 
false positive and false negative classifications of malingering. 
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Chapter III 
Results 
Differential Symptom Presentation 
 
 In order to investigate the symptom presentation of individuals who were 
malingering, the Restructured Clinical (RC) scales on the MMPI-2-RF were also 
evaluated. Differences between the three malingering groups were analyzed using a one-
way MANOVA. The overall multivariate analysis of variance (MANOVA) for the three 
malingering groups was significant, Wilk’s Lambda = .555, F (18, 324) = 6.154, p <.001. 
Six of the nine Restructured Clinical scales were found to differ significantly across all 
three of the groups (Incentive Only to Possible, and Possible to Probable/Definite), with 
RC3 (Cynicism), RC4 (Antisocial Behavior), and RC9 (Hypomanic Activation) being the 
exceptions. Among the three exceptions, however, RC3 and RC4 were found to differ 
significantly from the Incentive Only to the Probable/Definite malingering groups. 
Interestingly, RC8 (Aberrant Experiences) and RC6 (Ideas of Persecution) were found to 
differ between the groups most significantly. Following closely behind, as may be 
expected, RCd (Demoralization) and RC1 (Somatic Complaints) were found to have the 
third and fourth greatest significant differences, suggesting that individuals classified as 
malingering pain endorsed symptoms consistent with feeling sad and unhappy, reporting 
multiple somatic complaints, and experiencing unusual thought and perceptual processes 
on the MMPI-2-RF.  Results of the MANOVA analysis can be seen in Table 4 with the 
mean restructured clinical scale profiles presented in Figure 2.  
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Validity Scale Malingering Group Differences 
 Each of the MMPI-2-RF validity scales and RBS were compared across the 
malingering classification groups. For the purpose of these analyses, the Probable 
Malingering group and Definite Malingering groups were combined due to the small size 
of each group. The combination of these two groups in malingering studies has been 
utilized in previous work (Greve et al., 2006, Greve et al., 2009; Larrabee, 2003).  
 A one-way analysis of variance (ANOVA) was conducted in order to determine 
the differences in the MMPI-2-RF over-reporting validity scales across each of the three 
malingering group classifications. The individual validity scales were then compared 
across each group. Each of the over-reporting validity scale scores in the 
Probable/Definite Malingering group was significantly higher in comparison to the 
scores in the Incentive Only group, which is presented in Table 3. In addition, each over-
reporting validity scale with the exception of Fp-r there was significantly higher in the 
Possible Malingering groups. Mean scores for each of the scales are shown in Figure 1.   
 Cohen’s d effect size estimates were calculated between the Incentive Only and 
Probable/Definite Malingering groups. As hypothesized, RBS rendered the largest effect 
(d = 1.67), followed closely by F-r (d = 1.63).  Fs and FBS-r also rendered large effect 
sizes with d = 1.37 and 1.16, respectively. Finally, not surprisingly given the nature of the 
forensic context in this sample, Fp-r was found to have the lowest effect size (d = .93). In 
addition, comparisons were made between the Incentive Only and Possible Malingering 
groups. Four of the five scales, with Fp-r being the one exception, showed utility in 
differentiating between these two groups. Fs was found to have the best utility in 
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discriminating between the two groups, followed closely by F-r and RBS. The results of 
these analyses are also presented in Table 3. 
 
Classification Accuracy 
 
Table 2 provides the classification accuracy of the MMPI-2-RF over-reporting 
validity scales. In addition, this table shows the sensitivity, specificity, and predictive 
powers for hypothetical base rates ranging from .10 to .50 for these five scales. The 
Incentive Only and Possible Malingering groups were combined and compared with the 
Probable/Definite Malingering group for the purpose of these analyses.  
In regards to classification accuracy, it was found that lower cutoff scores for the 
scales generally yielded good sensitivity, at the loss of specificity. As cutoff scores were 
increased, specificity increased. For instance, when analyzing the over-reporting scales at 
the lowest cutoff, RBS = 80 and FBS = 80 were found to have excellent sensitivity and 
good specificity (.94/.62 and .90/.56, respectively). F-r and Fs were found to render good 
sensitivities of .74 and .56, respectively at the lowest cutoffs (F-r = 90 and Fs = 80), with 
specificities of .81 and .90. Fp-r was an exception, however, and showed low sensitivity 
(.26) with high specificity (.97) at the lowest cutoff (Fp-r = 70). As the cutoffs were 
increased, the specificity increased in all cases (naturally, with decreased sensitivities). At 
the highest cutoffs, F-r (F-r = 120) had a sensitivity of .30 and specificity of .99, Fp-r 
(Fp-r = 100) had a sensitivity of .07 and a specificity of 1.00, Fs (Fs = 100) had a 
sensitivity of .26 and a specificity of 1.00, FBS (FBS = 100) had a sensitivity of .16 and 
specificity of .99, and RBS (RBS = 100) had a sensitivity of .44 and a specificity of .93. 
These results in addition to the sensitivities and specificities at alternate cut-off scores 
can be seen in Table 2.  
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 Given that in clinical settings, psychologists will typically examine the complete 
set of validity scales together when reviewing MMPI-2-RF results, the classification 
accuracy of the scales was examined together as well. When any one scale was elevated 
(regardless of which particular scale was elevated), a sensitivity of .80 and specificity of 
.71 was found. When two scales were elevated (again, regardless of which particular 
scales were elevated), there was a sensitivity of .88 and specificity of .85. Finally, when 
three scales were elevated, a sensitivity of .94 and a specificity of .89 were found. These 
results are also exhibited in Table 2.    
 In addition to analyzing the sensitivities and specificities of each scale, the 
positive and negative predictive powers were also evaluated and can also be seen in Table 
2. These estimates indicate the malingering classification probability at a certain cut-off. 
Due to the fact that estimates of predictive power are heavily influenced by the base-rate 
of the condition, positive and negative predictive powers were analyzed at hypothetical 
base rates ranging from .10 to .50.  
 Generally, acceptable positive predictive power (PPP) rates were found with 
increased base rates and cut-off scores for these scales. For instance, F-r reached a PPP of 
.80 at the lowest cut-off, only when the base rate was set at .50. On the other hand, F-r 
reached a PPP of .88 at a base rate of .20, but at the highest cut-off. Similar patterns were 
found for both Fp-r and Fs. In the case of FBS-r and RBS, however, it was found that 
regardless of the base rate, PPP was not at or above .80 at the lowest cut-offs. In addition, 
on RBS, even with a higher cut-off score, a base rate of .40 was still needed in order to 
obtain a PPP of at least .80. 
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Chapter IV 
Discussion 
The current study investigates the association between the MMPI-2-RF over-
reporting validity scales and structured malingered pain criteria among a sample of civil 
litigants claiming symptoms of chronic pain. The purposes of this study was to examine 
the utility of the MMPI-2-RF over-reporting validity scales in the classification of 
malingered pain disability. 
Overall, the over-reporting validity scales of the MMPI-2-RF were found to have 
good utility in the detection of malingered pain related disability. Each of the scales was 
found to be significantly higher between the Incentive Only and the Probable/Definite 
Malingering groups. As expected, RBS and F-r were found to have the greatest effect 
sizes in making these comparisons. This is not surprising given the basis for the 
construction of each of these scales. In particular, the high performance of RBS was 
expected given that the scale was constructed in order to predict the failure of cognitive 
SVT’s and the Bianchini et al. (2005) MPRD criteria include performance on SVTs. This 
study shows evidence that RBS is in fact performing as intended. Also as hypothesized, 
Fp-r had the lowest effect size. This is also not surprising, because individuals in a civil 
forensic disability context are not as likely to be presenting symptoms of severe mental 
illness (Wygant et al., 2007). In regard to Fs and FBS-r, promising findings were also 
obtained. Though the effect sizes were much smaller than those found for F-r and RBS in 
this study, both Fs and RBS-r did show utility in distinguishing all three malingering 
groups. These results are consistent with previous research of these scales on their use in 
civil forensic contexts (Wygant et al., 2009, 2010) which have found the over-reporting 
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validity scales to have utility in distinguishing malingering groups among disability 
litigants, particularly F-r and RBS. In addition, given that sensitivity and specificity 
increased as more than one scale was utilized at a time to make a malingering diagnosis, 
this research supports the use of the over-reporting validity scales as a whole. Clinicians 
are especially encouraged to use the over-reporting scales of the MMPI-2-RF in 
combination with one another in order to assist making malingering determinations. In 
terms of classification accuracy, it was generally found that having low cut-off scores 
yielded good sensitivity at the loss of specificity. When the cut-off scores were raised, 
specificity also rose, but of course at the loss of sensitivity. Since validity scales of the 
MMPI-2-RF are intended to be analyzed as a whole, and determinations are not 
suggested to be made on the basis of one scale, classification accuracy was found for 
multiple scale elevations, which yielded positive findings. When more than one scale was 
elevated, high rates were found for both sensitivity and specificity. In terms of cut-off 
scores to be used for each of these over-reporting scales, it would be suggested that lower 
cut-off scores be utilized in order to increase the sensitivity of the measure. While if the 
MMPI-2-RF were being utilized alone in order to classify individuals as malingering or 
non-malingering, these lower cut-off scores would render a high rate of false-positives, 
the practice of using one measure for malingering determination would be considered 
poor clinical judgment. Therefore, it is suggested that the lower cut-off scores of the 
over-reporting scales on the MMPI-2-RF be utilized as one piece of evidence in a large 
battery of measures used to determine the level of symptom over-reporting. Furthermore, 
it is suggested that the MMPI-2-RF be utilized as a screening measure with the use of 
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lower cut-off scores in order to determine which individuals need to be tested further for 
symptom feigning or magnification.  
The hypothesis was generally supported that the Restructured Clinical scales of 
the MMPI-2-RF would be significantly elevated in the Probable/Definite Malingering 
group in comparison to the Possible Malingering and Incentive Only groups in a 
theoretically consistent manner. Eight of the nine scales were found to be significantly 
higher in the Probable/Definite Malingering group compared to the Incentive Only group 
(with RC9, Hypomanic Activation, being the one exception). This shows that, as would 
be expected, and even assumed, those classified as malingering were endorsing a greater 
amount of symptoms. Most expectedly, RC1 (Somatic Complaints) was among the scales 
with the greatest significant differences between the groups. This finding is not surprising 
given that the sample consisted of individuals claiming chronic pain and RC1 includes 
items reflecting somatic dysfunction. Also not surprising, RCd was significantly elevated 
in the malingering group, suggesting that these litigants were presenting themselves as 
depressed, pessimistic, and dejected. Interestingly, RC8 (Aberrant Experiences) exhibited 
the largest difference between the groups. This is inconsistent with previous studies (e.g., 
Larrabee, 2003; Wygant et al., 2007), which suggests that disability litigants are unlikely 
to report symptoms of severe psychopathology (e.g., psychosis). Further research would 
be needed in order to formulate hypotheses for why these results were found, such as 
evaluating whether there was a pattern with the malingering individuals elevating this 
scale in regards to which specific items were being endorsed.  
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Limitations and Future Directions 
 
 The current study is not without its limitations. The first of these limitations is 
that the present investigation did not include a non-litigating clinical comparison group. 
Though there were individuals who were classified as “non-malingering”, these 
individuals were not a “no incentive” group as each individual did have a financial 
incentive at stake. Since previous research has shown that “no incentive” and “incentive 
only” groups can actually differ in their symptom presentation (Bianchini et al., 2008), 
this is a limitation of the current study. Future research in regards to the use of multi-
method malingered pain detection criteria should utilize a comparison group of 
individuals without an incentive to exaggerate their symptoms. An optimal choice for 
such group would include a sample of non-litigating chronic pain patients.   
In addition, a second limitation of the current study is the lack of a specific 
somatic malingering measure administered in the testing battery. This is indeed a 
challenge to the field in general, as there are few validated measures used to detect 
malingered somatic symptoms, but the present study would have been made stronger had 
the few validated measures used for this detection been utilized in this sample. For 
instance, future research in this area should use measures such as the Modified Somatic 
Perception Questionnaire (MSPQ; Main, 1983) and Waddell’s signs of non-organic pain 
(Waddell, McCulloch, Kummel, & Venner, 1980) in order to better validate the use of the 
MMPI-2-RF over-reporting validity scales, particularly the Fs scale, in the detection of 
malingered pain. Future research in the general field of somatic malingering should also 
investigate expanding the options for somatic malingering measures. When a greater 
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number of measures are available for this purpose, the study of the MMPI-2-RF in 
relation to this topic will be more simple and meaningful.   
 In conclusion, the results of this study are generally supportive of the use of the 
MMPI-2-RF in the detection of malingered pain related disability. A strength of the 
present study was the use of the Bianchini et al. Malingered Pain-Related Disability 
criteria in order to classify individuals on a continuum of malingering. This gives a more 
accurate classification than the use of single response bias criteria, and therefore creates a 
more stringent analysis of the MMPI-2-RF over-reporting validity scales. Results were 
very promising in that even under the more strict conditions of the structured malingering 
criteria, the MMPI-2-RF validity scales performed very well in the classification of 
malingering. In addition,the over-reporting validity scales were found to have good 
sensitivity and specificity, which support the use of the mMMPI-2-RF in the use of 
screening individuals for possible malingering symptomatology. Finally, the hypotheses 
put forth were generally supported and it would be expected that the MMPI-2-RF over-
reporting validity scales will continue to perform well in the use of detecting malingered 
pain related disability.  
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Table 1 
Scoring criteria for response bias measures 
Measure Pass Below Cutoff Below Chance Source 
LMT > 93% < 93% correct N/A Inman et al. (1998) 
TOMM > 90% Trial 2/ Retention 36 - 89.99% (Trial 2/ Retention) < 36% (Trial 2/ Retention) TOMM Manual 
VSVT  > 30 (Total Correct)  or  
> 16 (Easy/Difficult Correct) 
18 - 29 (Total Correct), or  
8 - 15 (Easy/Difficult Correct) 
< 17 (Total Correct), or  
< 7 (Easy/Difficult Correct) 
VSVT Manual 
 Above Cutoff  Source 
M-FAST > 6Total Score M-FAST Manual 
SIMS  > 23Total Score Wisdom et al. (2010) 
SIRS > 1 Primary Scale in Definite Range, or > 3 Primary Scales in Probable Range, or Total Score > 76 SIRS Manual 
Sources: Inman, T.H., Vickery, C.D., Berry, D.T.R., Lamb, D.G., Edwards, C.L., & Smith, G.T. (1998). Development and initial validation of a 
new procedure for evaluating adequacy of effort given during neuropsychological testing: The Letter Memory Test. Psychological 
Assessment, 10, 128-139.; Miller, H.A. (2001). Miller Forensic Assessment of Symptoms Test (M-FAST) and professional manual. Lutz, 
FL: Psychological Assessment Resources.; Rogers, R., Bagby, R.M., & Dickens, S.E. (1992). Structured Interview of Reported Symptoms 
(SIRS) and professional manual. Odessa, FL: Psychological Assessment Resources.; Slick, D.J., Hopp, G., & Strauss, E. (1995). The 
Victoria Symptom Validity Test. Odessa, FL: Psychological Assessment Resources.; Tombaugh, T.N. (1996). Test of Memory Malingering 
(TOMM). New York: Multi Health Systems.; Wisdom, N., Callahan, J., & Shaw, T. (2010). Diagnostic Utility of the Structured Inventory 
of Malingered Symptomatology to Detect Malingering in a Forensic Sample. Archives of Clinical Neuropsychology, 25, 118-125. 
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Table 2 
Classification Accuracy and Predictive Power (Incentive Only vs. Probable/Definite Malingering) 
      Predictive Power: Positive/Negative 
 Cutoff SENS SPEC  BR .10 .20 .30 .40 .50 
F-r 90 .74 .81   .30/.97 .49/.93 .63/.88 .72/.82 .80/.76 
 100 .59 .87   .34/.95 .53/.89 .66/.83 .75/.76 .82/.68 
 110 .46 .94   .46/.94 .66/.87 .77/.80 .84/.72 .88/.64 
 120 .30 .99   .77/.93 .88/.85 .93/.77 .95/.68 .97/.59 
Fp-r 70 .26 .97   .49/.92 .68/.84 .79/.75 .85/.66 .90/.57 
 80 .16 .97   .37/.91 .57/.82 .70/.73 .78/.63 .84/.54 
 90 .13 .99   .59/.91 .76/.82 .85/.73 .90/.63 .93/.53 
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Table 2 (Continued) 
 Cutoff SENS SPEC  BR .10 .20 .30 .40 .50 
 100 .07 1.00   1.00/.91 1.00/.81 1.00/.72 1.00/.62 1.00/.52 
Fs 80 .56 .90   .38/.95 .58/.89 .71/.83 .79/.75 .85/.67 
 90 .46 .96   .56/.94 .74/.88 .83/.81 .88/.73 .92/.64 
 100 .26 1.00   1.00/.92 1.00/.84 1.00/.76 1.00/.67 1.00/.57 
FBS-r 80 .90 .56   .19/.98 .34/.96 .47/.93 .58/.89 .67/.85 
 90 .47 .82   .22/.93 .39/.86 .53/.78 .64/.70 .72/.61 
 100 .16 .99   .64/.91 .80/.83 .87/.73 .91/.64 .94/.54 
RBS 80 .94 .62   .22/.99 .38/.98 .51/.96 .62/.94 .71/.91 
 90 .74 .82   .31/.97 .51/.93 .64/.88 .73/.83 .80/.76 
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Table 2 (Continued) 
 Cutoff SENS SPEC  BR .10 .20 .30 .40 .50 
 100 .44 .93   .41/.94 .61/.87 .73/.79 .81/.71 .86/.62 
Multiple  1 Elevation .80 .71   .23/.97 .41/.93 .54/.89 .65/.84 .73/.78 
Scales 2 Elevations .88 .85   .39/.98 .59/.97 .72/.94 .80/.91 .85/.88 
 3 Elevations .94 .89   .49/.99 .68/.98 .79/.97 .85/.96 .90/.94 
Note. MND = Malingered Neurocognitive Dysfunction. SENS = Sensitivity, SPEC = Specificity, BR = Hypothetical Base 
Rate. Multiple Scales utilized a combination of scales and considered an individual to be classified as malingering if F-r > 
95, Fp-r > 70, Fs > 90, FBS-r > 90, or RBS > 90. 
 
 
 
 
 
 
56 
 
 
APPENDIX C: 
MMPI-2-RF Validity Scales and Criteria for MPRD 
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Table 3 
MMPI-2-RF validity scales and criteria for Malingered Pain Related Disability 
 Malingered Pain Related Disability Classification  
 
Incentive 
Only  
 (n = 68) 
Possible  
Malingering  
(n = 34) 
Probable/Definite 
Malingering  
(n = 67) ANOVA Effect Size 
 M SD M SD M SD F (2,166) p  d 
F-r 72.46a 19.078 86.78b 20.101 106.73c 22.835 45.82 <.001 .36 1.63 
FP-r 51.91a 10.277 57.69a 12.921 64.93b 16.993 15.03 <.001 .07 0.93 
FS 59.63a 13.792 75.69b 18.072 85.32c 22.761 32.45 <.001 .28 1.37 
FBS-r 75.26a 14.281 84.03b 14.181 90.01b 10.834 21.90 <.001 .21 1.16 
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Table 3 (Continued) 
 M SD M SD M SD F (2,166) p  d 
RBS 72.61a 17.224 87.07b 14.292 98.51c 13.549 48.67 <.001 .37 1.67 
Note. Means for all three groups were significantly different for each scale (Tukey HSD). F-r = Infrequent Responses; FP-r = 
Infrequent Psychopathology Responses; FS = Infrequent Somatic Responses; FBS-r = Symptom Validity. RBS = Response Bias Scale. 
Cohen’s d calculated between Incentive Only and Probable/Definite Malingering groups. 
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APPENDIX D: 
MMPI-2-RF Restructured Clinical Scales and Criteria for MPRD 
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Table 4 
MMPI-2-RF restructured clinical scales and criteria for Malingered Pain Related Disability 
 Malingered Pain Related Disability Classification 
 
Incentive 
Only  
 (n = 68) 
Possible  
Malingering  
(n = 35) 
Probable/Definite 
Malingering  
(n = 70) ANOVA 
 M SD M SD M SD F (2,162) p d 
RCd 65.51a 11.024 71.23b 11.892 77.99c 6.392 28.97 <.001 1.13 
RC1 72.40a 12.955 81.29a 11.834 86.86b 9.657 27.57 <.001 1.12 
RC2 70.10a 13.020 75.89b 13.286 84.21c 10.875 23.05 <.001 1.08 
RC3 53.90a 12.633 55.80ab 11.852 60.90b 11.975 5.92 .003 0.55 
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Table 4 (Continued) 
 M SD M SD M SD F (2,162) p d 
RC4 47.97a 8.760 47.00 ab 10.224 51.90b 10.836 3.94 .021 0.45 
RC6 52.82a 10.172 57.54a 12.668 67.97b 15.592 23.78 <.001 1.49 
RC7 56.69a 11.970 63.34b 13.647 69.96c 11.862 20.12 <.001 1.11 
RC8 49.76a 10.512 56.83b 14.537 67.83c 14.344 33.60 <.001 1.72 
RC9 43.85a 8.706 44.20a 11.631 46.43a 10.182 1.29 .279 0.30 
Note. RCd = Demoralization; RC1 = Somatic Complaints; RC2 = Low Positive Emotions; RC3 = Cynicism; RC4 = Antisocial 
Behavior; RC6 = Ideas of Persecution; RC7 = Dysfunctional Negative Emotions; RC8 = Aberrant Experiences; RC9 = Hypomanic 
Activation. Cohen’s d calculated between Incentive Only and Probable/Definite Malingering groups. 
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APPENDIX E: 
Mean Over-Reporting Validity Scale Score
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 Figure 1. Mean Over-Reporting Validity Scale Scores
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APPENDIX F: 
Mean Restructured Clinical Scale Scores 
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 Figure 2. Mean Restructured Clinical Scale Scores 
 
